MoonLake Immunotherapeutics (MLTX) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 396.64M | 421.69M | 411.21M | 455.48M | 506.26M | 474.29M | 512.32M | 536.88M | 553.59M | 514.17M | 500.01M | 506.37M | 66.5M | 76.51M | 88.54M | 98.38M | 116.16M | 9.64M | 1.21M | 1.33M |
| Cash & Short-Term Investments | 357.92M | 393.97M | 380.48M | 425.08M | 480.13M | 448.03M | 493.92M | 519.8M | 547.05M | 511.01M | 495.98M | 501.79M | 63.05M | 72.11M | 83.46M | 92.71M | 101.02M | 8.04M | 1.03M | 1.1M |
| Cash Only | 298.49M | 334.52M | 350.74M | 306.68M | 271.57M | 180.43M | 375.66M | 342.79M | 458.44M | 451.17M | 318.17M | 501.79M | 50.13M | 39.51M | 41.2M | 92.71M | 101.02M | 8.04M | 1.03M | 1.1M |
| Short-Term Investments | 59.43M | 59.45M | 29.74M | 118.4M | 208.56M | 267.6M | 118.27M | 177.01M | 88.61M | 59.84M | 177.81M | 0 | 12.92M | 32.61M | 42.25M | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 5.76M | 4.87M | 4.02M | 3.41M | 2.99M | 2.84M | 2.41M | 1.68M | 1.5M | 1.06M | 720.75K | 619.77K | 378.44K | 217.13K | 600.54K | 557.05K | 15M | 148.77K | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 32.96M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 3.73M | 2.74M | 3.12M | 4.62M | 5M | 3.64M | 5.9M | 8M | 10.53M | 12.37M | 208.94K | 254.05K | 292.36K | 331.97K | 52.68K | 55.97K | 115.05M | 45.74K | 115.04M | 115.04M |
| Property, Plant & Equipment | 2.39M | 2.14M | 2.53M | 2.92M | 3.3M | 3.64M | 3.83M | 3.87M | 4.21M | 3.95M | 208.94K | 254.05K | 292.36K | 331.97K | 52.68K | 55.97K | 59.26K | 45.74K | 29.85K | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 115.05M | 0 | 115.04M | 115.04M |
| Other Non-Current Assets | 1.34M | 596K | 587K | 1.7M | 1.7M | 0 | 2.06M | 4.13M | 6.32M | 8.42M | 0 | 0 | 0 | 0 | 0 | 0 | -59.26K | 0 | -29.85K | 0 |
| Total Assets | 400.37M | 424.43M | 414.33M | 460.1M | 511.26M | 477.93M | 518.21M | 544.88M | 564.12M | 526.54M | 500.22M | 506.62M | 66.8M | 76.84M | 88.59M | 98.43M | 231.21M | 9.68M | 116.25M | 116.37M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -21.69% | -11.19% | -20.05% | -15.56% | -9.37% | -9.23% | 3.6% | 7.55% | 744.53% | 585.21% | 464.63% | 414.68% | -71.11% | 693.63% | -23.79% | -15.41% | 98.48% | - | - | - |
| Total Current Liabilities | 46.11M | 45.48M | 48.37M | 27.36M | 23.98M | 22.46M | 20.08M | 12.28M | 8.91M | 9.97M | 10.31M | 7.13M | 7.28M | 7.67M | 6.02M | 3.86M | 202.79M | 21.09M | 2.06M | 90K |
| Accounts Payable | 0 | 0 | 0 | 14.89M | 10.06M | 8.68M | 10.26M | 4.76M | 3.09M | 1.46M | 824.07K | 270.75K | 510.52K | 65.98K | 155.53K | 246.75K | 0 | 1.23M | 0 | 0 |
| Days Payables Outstanding | - | - | - | 1.53K | - | - | 21.25K | - | - | - | - | - | - | - | - | - | - | 45.61K | - | - |
| Short-Term Debt | 920K | 1.23M | 1.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15.15M | 15M | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -213.45K | 0 | 0 | 0 |
| Other Current Liabilities | 45.19M | 40.83M | 41.66M | 3.23M | 2.54M | 4.24M | 2.92M | 1.96M | 1.2M | 2.78M | 2.76M | 904.08K | 547.89K | 1.11M | 217.14K | 530.71K | 182.57M | 1.42M | 2.06M | 90K |
| Current Ratio | 8.60x | 9.27x | 8.50x | 16.65x | 21.11x | 21.11x | 25.51x | 43.71x | 62.13x | 51.59x | 48.51x | 70.97x | 9.14x | 9.98x | 14.71x | 25.51x | 0.57x | 0.46x | 0.59x | 14.79x |
| Quick Ratio | 8.60x | 9.27x | 8.50x | 16.65x | 21.11x | 21.11x | 25.51x | 43.71x | 62.13x | 51.59x | 48.51x | 70.97x | 9.14x | 9.98x | 14.71x | 25.51x | 0.57x | 0.46x | 0.59x | 14.79x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 100.24M | 74.47M | 74.78M | 74.79M | 74.7M | 2.08M | 2.63M | 2.56M | 2.82M | 3.08M | 268.48K | 376.61K | 405.25K | 411.16K | 4.99K | 18.59K | 4.03M | 239.86K | 4.03M | 4.03M |
| Long-Term Debt | 99.88M | 74.47M | 73.74M | 73.38M | 73.02M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 374K | 486K | 836K | 1.14M | 1.46M | 1.94M | 2.02M | 2.36M | 2.5M | 13.08K | 53.02K | 91.08K | 128.95K | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 353K | -374K | 549K | 574K | 536K | 620.68K | 694.96K | 541.95K | 462.74K | 583.43K | 255.4K | 323.6K | 314.17K | 282.21K | 4.99K | 18.59K | 4.03M | 239.86K | 4.03M | 4.03M |
| Total Liabilities | 146.35M | 119.95M | 123.14M | 102.15M | 98.68M | 24.54M | 22.71M | 14.85M | 11.73M | 13.05M | 10.58M | 7.51M | 7.68M | 8.08M | 6.02M | 3.88M | 206.82M | 21.33M | 6.08M | 4.12M |
| Total Debt | 100.8M | 75.71M | 75.73M | 75.77M | 75.6M | 2.83M | 3.69M | 3.34M | 3.66M | 3.7M | 169.42K | 211.24K | 246.25K | 282.58K | 0 | 0 | 15.15M | 15M | 0 | 0 |
| Net Debt | -197.69M | -258.81M | -275.01M | -230.91M | -195.97M | -177.6M | -371.97M | -339.45M | -454.78M | -447.47M | -318M | -501.58M | -49.88M | -39.22M | -41.2M | -92.71M | -85.87M | 6.96M | -1.03M | -1.1M |
| Debt / Equity | 0.40x | 0.25x | 0.26x | 0.21x | 0.18x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | - | - | 0.62x | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -30.86x | -30.46x | -21.07x | -26.47x | -2243.78x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 254.02M | 304.48M | 291.19M | 357.94M | 412.58M | 453.39M | 495.5M | 530.03M | 552.39M | 513.49M | 489.64M | 499.11M | 59.11M | 68.77M | 82.57M | 94.56M | 24.4M | -11.65M | 110.16M | 112.26M |
| Equity Growth % | -38.43% | -32.84% | -41.23% | -32.47% | -25.31% | -11.7% | 1.2% | 6.2% | 834.47% | 646.71% | 493.02% | 427.83% | 142.31% | 690.53% | -25.05% | -15.77% | -78.3% | - | - | - |
| Book Value per Share | 3.56 | 4.72 | 4.60 | 5.66 | 6.52 | 7.19 | 7.88 | 8.43 | 8.82 | 8.57 | 9.15 | 11.42 | 1.51 | 1.77 | 2.24 | 2.69 | 0.66 | -0.32 | 2.98 | 3.04 |
| Total Shareholders' Equity | 254.02M | 304.48M | 288.91M | 353.73M | 407.52M | 446.83M | 488.2M | 520.66M | 542.55M | 495.68M | 424.93M | 489.8M | 42M | 48.9M | 55.29M | 63.51M | 24.4M | -11.65M | 110.16M | 112.26M |
| Common Stock | 7K | 7K | 6K | 6K | 6K | 6.39K | 6.39K | 6.39K | 6.39K | 6.3K | 6.25K | 6.25K | 5.27K | 5.27K | 5.27K | 5.27K | 673 | 38.54K | 115M | 107.26M |
| Retained Earnings | -532.62M | -462.91M | -400.49M | -330.76M | -275.54M | -235.59M | -189.99M | -154.6M | -130.33M | -116.66M | -109.22M | -99.79M | -89.66M | -80.65M | -68.79M | -58.68M | -9.76M | -53.64M | -4.84M | -319.46K |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.2K | 0 | 0 |
| Accumulated OCI | 322K | 604K | 278K | 520K | 2.39M | 5M | 2.83M | 3.26M | 2.69M | 2.36M | 2.88M | 35.12K | 340.11K | 350.95K | 245.28K | 133.72K | 98.09K | -168.18K | 0 | 0 |
| Minority Interest | 0 | 0 | 2.29M | 4.21M | 5.06M | 6.57M | 7.31M | 9.37M | 9.83M | 17.82M | 64.71M | 9.31M | 17.11M | 19.87M | 27.28M | 31.04M | 0 | 0 | 0 | 0 |